PLUS THERAPEUTICS, INC. Annual Interest Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Plus Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
  • Plus Therapeutics, Inc. Interest Expense for the quarter ending June 30, 2024 was $27K, a 75.9% decline year-over-year.
  • Plus Therapeutics, Inc. Interest Expense for the twelve months ending June 30, 2024 was $210K, a 63.7% decline year-over-year.
  • Plus Therapeutics, Inc. annual Interest Expense for 2023 was $395K, a 44.4% decline from 2022.
  • Plus Therapeutics, Inc. annual Interest Expense for 2022 was $711K, a 23.7% decline from 2021.
  • Plus Therapeutics, Inc. annual Interest Expense for 2021 was $932K, a 15.8% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $395K -$316K -44.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $711K -$221K -23.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $932K -$175K -15.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-23
2020 $1.11M -$748K -40.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $1.86M -$67K -3.49% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-22
2018 $1.92M -$127K -6.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $2.05M -$543K -20.9% Jan 1, 2017 Dec 31, 2017 8-K 2019-09-10
2016 $2.59M -$787K -23.3% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-09
2015 $3.38M -$992K -22.7% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-24
2014 $4.37M +$975K +28.7% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-11
2013 $3.4M +$10K +0.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-11
2012 $3.39M +$602K +21.6% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 $2.78M +$732K +35.7% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 $2.05M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.